BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37145846)

  • 1. X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma.
    Ren Y; Wang Y; Liu J; Liu T; Yuan L; Wu C; Yang Z; Chen J
    J Med Chem; 2023 May; 66(10):6697-6714. PubMed ID: 37145846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities.
    Ren Y; Wang Y; Li G; Zhang Z; Ma L; Cheng B; Chen J
    J Med Chem; 2021 Apr; 64(8):4498-4515. PubMed ID: 33788562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects.
    Peng X; Ren Y; Pan W; Liu J; Chen J
    J Med Chem; 2023 Jan; 66(1):627-640. PubMed ID: 36516438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site.
    Tan L; Wu C; Zhang J; Yu Q; Wang X; Zhang L; Ge M; Wang Z; Ouyang L; Wang Y
    J Med Chem; 2023 Mar; 66(5):3588-3620. PubMed ID: 36802449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Lin S; Du T; Zhang J; Wu D; Tian H; Zhang K; Jiang L; Lu D; Sheng L; Li Y; Ji M; Chen X; Xu H
    J Med Chem; 2022 Dec; 65(24):16372-16391. PubMed ID: 36511661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
    Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
    Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
    Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
    Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
    Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel
    Leng J; Zhao Y; Sheng P; Xia Y; Chen T; Zhao S; Xie S; Yan X; Wang X; Yin Y; Kong L
    J Med Chem; 2022 Dec; 65(24):16774-16800. PubMed ID: 36471625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
    Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
    Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation.
    Liu W; He Y; Guo Z; Wang M; Han X; Jia H; He J; Miao S; Wang S
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2155815. PubMed ID: 36629423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
    Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
    Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.
    Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C
    Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulin Inhibitors Binding to Colchicine-Site: A Review from 2015 to 2019.
    Xia LY; Zhang YL; Yang R; Wang ZC; Lu YD; Wang BZ; Zhu HL
    Curr Med Chem; 2020; 27(40):6787-6814. PubMed ID: 31580244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
    Arnst KE; Wang Y; Hwang DJ; Xue Y; Costello T; Hamilton D; Chen Q; Yang J; Park F; Dalton JT; Miller DD; Li W
    Cancer Res; 2018 Jan; 78(1):265-277. PubMed ID: 29180476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
    Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
    Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
    Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
    Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.